Nxera Pharma Revenue
Biotechnology Research • 
Minato-Ku, Tokyo, Japan • 201-500 Employees
Nxera Pharma revenue & valuation
| Annual revenue | $197,000,000 |
| Revenue per employee | $642,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $630,400,000 |
| Total funding | No funding |
Key Contacts at Nxera Pharma
Nicola Rabson
Non Executive Director
Liu Shi
Associate Director Of Bioinformatics & Biomarkers
Wendy Winchester
Senior Director
David Bedford
Associate Director - Translational Sciences, Metabolism
Adam Ciezarek
Director Of Quality
Charlotte Fieldhouse
Director Of Medicinal Chemistry
Kenny Hunt
Director Data Architecture & Analytics
Mathieu Rappas
Senior Director Protein Sciences
Marsilio Adriani
Associate Director ‑ Translational Sciences
Lizzie Lovell
Senior Director, Head Of Legal Technical Operations
Company overview
| Headquarters | 9-7-2 Akasaka, Minato-ku, Tokyo, Tokyo 1070052, JP |
| Website | |
| NAICS | 541714 |
| Keywords | Development, Gastroenterology, Neurology, Drug Discovery, Chemistry, Immunology, Computational Chemistry, Gpcr, Molecular Pharmacology, Pre-Clinical, Inflammatory, Novel Medicines, Structure-Based Drug Design Platform Capabilities |
| Founded | 1990 |
| Employees | 201-500 |
| Socials |
Nxera Pharma Email Formats
Nxera Pharma uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@nxera.life), used 97.4% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@nxera.life | 97.4% |
{first initial}.{last name} | j.doe@nxera.life | 2% |
About Nxera Pharma
Nxera Pharma (formerly Sosei Heptares) is a technology powered biopharma company, in pursuit of new specialty medicines to improve the lives of patients with unmet needs in Japan and globally. In addition to several products being commercialized in Japan, we are advancing an extensive pipeline of over 30 active programs from discovery through to late clinical stage internally and in partnership with leading pharma and biotech companies. This pipeline is focused on addressing major unmet needs in some of the fastest-growing areas of medicine across neurology, GI and immunology, metabolic disorders and rare diseases, and leverages the power of our unique and industry leading GPCR-targeted structure-based drug discovery “NxWave” platform to provide a sustainable source of best- or first-in-class candidates. Nxera employs over 350 talented people at key locations in Tokyo and Osaka (Japan), London and Cambridge (UK), Basel (Switzerland) and Seoul (South Korea) and is listed on the Tokyo Stock Exchange (ticker: 4565).
Employees by Management Level
Total employees: 201-500
Seniority
Employees
Employees by Department
Nxera Pharma has 107 employees across 13 departments.
Departments
Number of employees
Funding Data
Nxera Pharma has never raised funding before.
Nxera Pharma Tech Stack
Discover the technologies and tools that power Nxera Pharma's digital infrastructure, from frameworks to analytics platforms.
Analytics
CRM
JavaScript frameworks
Tag managers
Hosting
Programming languages
Security
Miscellaneous
JavaScript frameworks
UI frameworks
Miscellaneous
Miscellaneous
Singapore
United States
Canada
Israel
Frequently asked questions
4.8
40,000 users
